Ildiko Lingvay, MD, MPH, MSCS
Dr. Ildiko Lingvay is a Tenured Professor of Medicine in the Division of Endocrinology and Professor in the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center. Dr. Lingvay is the Medical Director of the Office of Clinical Trials Management, overseeing the institutional approval of all clinical trials at UT Southwestern. She is Board Certified both in Obesity Medicine as well as Endocrinology, Diabetes and Metabolism.
Dr Lingvay leads a program that focuses on clinical research in the field of obesity and type 2 diabetes. Her research interests span the spectrum from pathophysiology of the disease to treatment algorithms and comparative effectiveness of various therapeutic approaches. Dr Lingvay treats patients at the UT Southwestern clinics and hospitals as well as the Parkland Health & Hospital System.
Dr Lingvay is an active member of the American Diabetes Association, where she has served over the years on several committees, including the Organizing Committee for the Annual Scientific Sessions, Focus on Fellows Advisory Board, WIN-ADA Advisory Board, Grant Review Committee, and the Professional Practice Committee. She is on the Editorial Board of several journals, including Diabetes Care. She participated in nearly 100 clinical trials and has a special interest in cardiovascular outcome trials and obesity trials. She authored over 160 publications in major medical journals and authored chapters in several popular diabetes textbooks.
Learn more about Ildiko
